SCHEMBL11298202

SCHEMBL11298202

Fc1cc(CCl)c(F)c2c1OCCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1058222 0.81
SCHEMBL1052297 0.72 CYP2D6 (0.32)
SCHEMBL10915683 0.68 ALDH1A1 (0.38)
SCHEMBL1054578 0.68 ERBB2 (0.36)
SCHEMBL10779523 0.68
SCHEMBL1055386 0.67 L3MBTL1 (0.37)
SCHEMBL12345221 0.67 PARP1 (0.39)
SCHEMBL11554562 0.66 DPP4 (0.34)
SCHEMBL8724856 0.66
SCHEMBL1465286 0.65 CYP3A4 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0004794-B1 SUBSTITUTED BENZAZEPINES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1982-04-28 EP disclosed
EP-0004794-A2 Substituted benzazepines, processes for preparing them and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1979-10-17 EP disclosed
US-4171359-A DOPAMINERGIC ACTIVITY SMITHKLINE CORPORATION (US) 1979-10-16 US disclosed